Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F9MK9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,649
Award facts
- Contract value 100% obligated
- $20,648.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 22, 2026, for Repatha 140 mg/ml SureClick auto-injectors valued at $20,648.93. This firm fixed-price delivery order is scheduled for completion by January 23, 2026, and represents a non-competitive, non-set-aside award. The products will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels and reduce the risk of cardiovascular disease, reflecting the pharmaceutical company's role as a critical supplier of specialty medications to federal healthcare systems.
This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. This comprehensive IDC vehicle enables the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal government health systems. The company's consistent receipt of competitive awards for various pharmaceutical products demonstrates its established capability to efficiently fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F9MK9?
SPE2DR26F9MK9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F9MK9 worth?
The government has obligated $20,649 on SPE2DR26F9MK9.
Is contract SPE2DR26F9MK9 an order under another contract?
Yes. SPE2DR26F9MK9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MK9 competed?
The extent of competition for SPE2DR26F9MK9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award